Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 17 of 17 for “"KDM5"”.

  1. Analyzing The Interactions Of Kdm5/lid And Sin3 In Drosophila Melanogaster

    … deactylase RPD3 and a histone demethylase dKDM5/LID. Immunopurification of dKDM5/LID verifies a previously observed interaction with SIN3 and RPD3. Furthermore, deficiency of dKDM5/LID phenocopies deficiency of SIN3 in many cellular and developmental processes. Knockdown of both Sin3A and …

    wayne-thes Repository record for Analyzing The Interactions Of Kdm5/lid And Sin3 In Drosophila Melanogaster (opens in a new tab)

  2. The role of the lysine demethylases KDM5 and KDM6 in bone malignancies

    … (KDM) family remove methyl marks from histones. KDM5B removes methyl marks from histone H3 lysine 4 (H3K4) whereas KDM6A and KDM6B remove methyl marks from histone H3 lysine 27 (H3K27).</p> <p>In this thesis, GSK-J4, an inhibitor of KDM5B, KDM6A and KDM6B, is shown to impair viability in a range …

    oxford Repository record for The role of the lysine demethylases KDM5 and KDM6 in bone malignancies (opens in a new tab)

  3. Characterization of lysine demethylase KDM5 family: Substrate specificity and identification of potential novel non-histone substrates

    … and demethylation within histone proteins. The KDM5/JARID1 sub-family are 2-oxoglutarate and Fe(II)-dependent lysine-specific histone demethylases that are characterized by their Jumonji catalytic domains. This enzyme family is known to facilitate the removal of tri-/di-methyl modifications from …

    carleton Repository record for Characterization of lysine demethylase KDM5 family: Substrate specificity and identification of potential novel non-histone substrates (opens in a new tab)

  4. Novel Histone Demethylase Inhibitors Synergistically Enhance the Effects of a DNA Hypomethylating Agent in Breast Cancer Cells

    … in cancer. Recently, the H3K4 demethylase, KDM5B, was shown to be amplified and overexpressed in luminal breast cancer, making it an ideal target for chemotherapeutic intervention. In this study, we characterized the phenotypic and molecular effects of a novel group of KDM5 inhibitors, …

    jhu Repository record for Novel Histone Demethylase Inhibitors Synergistically Enhance the Effects of a DNA Hypomethylating Agent in Breast Cancer Cells (opens in a new tab)

  5. Functional analysis of the KDM5B demethylase: In vitro and in vivo studies

    The KDM5 family consists of four proteins, namely KDM5A, KDM5B, KDM5C and KDM5D. The KDM5 family of demethylase proteins counteract the tri-methylation of H3K4 and can function as transcriptional repressors. They can form a number of different multi-protein complexes that contain other …

    kings Repository record for Functional analysis of the KDM5B demethylase: In vitro and in vivo studies (opens in a new tab) Download PDF for Functional analysis of the KDM5B demethylase: In vitro and in vivo studies (opens in a new tab)

  6. Epigenetics of osteoblast differentiation within an inflammatory environment

    … histone deacetylase and lysine demethylase (KDM5) inhibitors promoted ALP activity in a dose dependent manner. TGF-β1 treatment upregulated the expression of the KDM5 isoforms. Moreover, shRNA knockdown of KDM5 promoted ALP activity. Through RNA sequencing, we observed profound changes in …

    oxford Repository record for Epigenetics of osteoblast differentiation within an inflammatory environment (opens in a new tab)

  7. The role of the histone demethylase KDM5B, in the normal and malignant mammary gland

    … implicated in human diseases including cancer. KDM5B belongs to the KDM5 family of histone demethylases, which catalyse the removal of the methyl group from the active tri-methyl mark, H3K4me3, thereby regulating transcription. KDM5B was first identified in our lab as being downregulated when …

    kings Repository record for The role of the histone demethylase KDM5B, in the normal and malignant mammary gland (opens in a new tab) Download PDF for The role of the histone demethylase KDM5B, in the normal and malignant mammary gland (opens in a new tab)

  8. Development of covalent inhibitors of KDM5B

    … several cancers. Reported inhibitors of KDM5 are commonly metal-chelators which bind in the cosubstrate 2-oxoglutarate (2-OG) binding site. The inhibitors are potent biochemically but suffer from poor selectivity over the closely-related KDM4 and poor cellular potency. An explanation for …

    oxford Repository record for Development of covalent inhibitors of KDM5B (opens in a new tab)

  9. Etablierung eines dreidimensionalen Kokulturmodells und Testung epigenetisch-aktiver Hemmstoffe beim Multiplen Myelom

    … epigenetischer eraser Proteine (panKDM, LSD1, KDM5, HDACs) ein.<br>Im Gegensatz zum LOT-Modell ermöglichte das CAMA-Modell mit seinen definierten konischen Mikrokavitäten die Ausbildung 3D-Plasmazellcluster und vermittelte eine Resistenzentwicklung der Myelom-Zellen gegenüber Behandlung mit …

    freiburg-diss Repository record for Etablierung eines dreidimensionalen Kokulturmodells und Testung epigenetisch-aktiver Hemmstoffe beim Multiplen Myelom (opens in a new tab)

  10. Identification of anti-resorptive and anti-cancer activities of epigenetic inhibitors

    … other cell populations. GSK-J4, an inhibitor for KDM5 and KDM6, was shown to upregulate the metallothioneins and induce the ATF4-mediated stress response in myeloma cells, whereas the KDM5B inhibitors causes cell cycle arrest rather than apoptosis.</p>

    oxford Repository record for Identification of anti-resorptive and anti-cancer activities of epigenetic inhibitors (opens in a new tab)

  11. Lysine Post-Translational Modifications of Saccharomyces Cerevisiae Chromatin Proteins

    … that the JmjC domain-containing protein Kdm5 demethylates methylated lysine 4 of histone H3 in vitro and in vivo, refuting the longstanding hypothesis that lysine methylation is irreversible. Second, we confirmed and characterized monomethylation of lysine 20 of histone H4. Its abundance …

    penn Repository record for Lysine Post-Translational Modifications of Saccharomyces Cerevisiae Chromatin Proteins (opens in a new tab)

  12. Assays and Inhibitors for JumonjiC Domain-Containing Histone Demethylases as Epigenetic Regulators

    … to be used with related demethylases JARID1A (KDM5A) and JMJD3 (KDM6B). This platform has been used in several lead structure screening campaigns using fragment-based drug discovery, rational design, virtual screening, and analogy-based and focused library screening.<br>Thus, several novel …

    freiburg-diss Repository record for Assays and Inhibitors for JumonjiC Domain-Containing Histone Demethylases as Epigenetic Regulators (opens in a new tab)

  13. CHARACTERIZING THE FUNCTION AND REGULATORY MECHANISMS OF THE HISTONE DEMETHYLASE KDM5B: INSIGHTS INTO THE COMPLEXITY OF EPIGENETIC REGULATION

    <p>KDM5b acts as a transcriptional repressor through its ability to demethylate tri-methylated lysine (K) 4 on histone H3 (H3K4me3). Demethylation of this histone modification leads to transcriptional repression and downstream biological effects on gene expression. KDM5b is involved in the …

    mcmaster Repository record for CHARACTERIZING THE FUNCTION AND REGULATORY MECHANISMS OF THE HISTONE DEMETHYLASE KDM5B: INSIGHTS INTO THE COMPLEXITY OF EPIGENETIC REGULATION (opens in a new tab)

  14. From Genetics to Neurodevelopment: Identifying the Role of the Chromatin Regulator KDM5A in Autism Spectrum Disorder

    … a forward genetics approach, we identified KDM5A as a candidate ASD gene, regulating vocalization and nest building in mice. We subsequently analyzed whole exome sequencing data from a clinical cohort and identified pathogenic KDM5A variants in patients with ASD. KDM5A encodes a chromatin …

    utswmed Repository record for From Genetics to Neurodevelopment: Identifying the Role of the Chromatin Regulator KDM5A in Autism Spectrum Disorder (opens in a new tab)

  15. Metabolic disruptions in oocytes and embryos modifies DNA and histone methylation and alters embryonic development

    … Translocase (TET) and lysine demethylase 5 (KDM5) protein families. Whilst it is understood that impaired metabolism alters the embryonic epigenetic profile, the mechanism remains unclear. The TCA cycle intermediary α-ketoglutarate is utilised as a substrate by TET1-3 and KDM5A-C in the …

    adelaide Repository record for Metabolic disruptions in oocytes and embryos modifies DNA and histone methylation and alters embryonic development (opens in a new tab)